Guidance recommends safe opioid tapers that emphasize shared decision making and modest dose reductions over time. Practitioners are encouraged to review the state’s complete taper guidance.
The second year of the quality improvement program will begin in late spring 2022. Program information for prescribers and organizations is available.
Providers seeking information about the new CME requirement and their OPIP status can access state licensure requirements on the about page.